Declan Doogan - 09 Jun 2022 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role: Director, 10%+ Owner
Signature: /s/ S. Halle Vakani, as Attorney-in-Fact
Issuer symbol: TENX
Transactions as of: 09 Jun 2022
Net transactions value: $0
Form type: 4
Filing time: 10 Jun 2022, 21:08:41 UTC
Previous filing: 11 Feb 2022
Next filing: 12 Aug 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TENX	Common Stock						3,070,000	09 Jun 2022	Direct	F1
holding	TENX	Common Stock						567,871	09 Jun 2022	By Declan Doogan 2021 GRAT DTD 03-04-2021	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TENX	Stock Option (right to buy)	Award	$0	+5,000		$0.000000	5,000	09 Jun 2022	Common Stock	5,000	$0.6200	Direct
holding	TENX	Stock Option (right to buy)						6,250	09 Jun 2022	Common Stock	6,250	$2.00	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On August 11, 2021, the Reporting Person mistakenly filed a Form 4 reporting an aggregate beneficial ownership of 2,502,129, instead of 3,070,000 as reflected in the current filing.
F2	Dr. Doogan's wife, Dorothy Doogan, is the trustee of the Trust. Dr. Doogan disclaims beneficial ownership of the shares held by the Trust except to the extent of his pecuniary interest therein.